Podcast: Innovating to Meet Reproductive Health Needs with Multipurpose Prevention Technologies
On this episode of “One World, One Health” podcast, Dr. Bethany Young Holt of PHI’s CAMI Health discusses Multipurpose Prevention Technologies (MPTs)—products that combine contraceptives with sexually transmitted infection (STI) prevention.
Do women get STIs as often as men? Why do women need MPTs? Aren’t condoms enough? What do these technologies look like?
On this episode of the “One World, One Health” podcast, Dr. Bethany Young Holt of PHI’s CAMI Health discusses Multipurpose Prevention Technologies (MPTs)—products that provide not just contraception, but protection against HIV and other sexually transmitted infections for people around the world.
Multipurpose Prevention Technologies — Innovating to Meet Women's Needs
Dr. Bethany Young Holt is the Founder and Director of PHI's CAMI Health, an organization dedicated to advancing the health of women and girls worldwide. She is also the Co-Founder and Director of the Initiative for MPTs (IMPT), and a Principal Investigator (PI) at the Public Health Institute. She is a lecturer in the Department of Public Health at California State University, Sacramento. She has over 25 years of experience working on health prevention programs and research projects in the United States, Africa, and South Pacific. Bethany holds a PhD in Epidemiology, an MPH in Maternal and Child Health from University of California, Berkeley, and a BS in Biology from the College of Wooster.
When you empower women to protect themselves around their health—when and if they want to have children—that improves not only the woman’s life, but the economic well-being of her family and the whole community. So when women are protecting themselves from HIV and unintended pregnancy, they’re protecting their children that are living and the ones that are to come.Dr. Bethany Young Holt
Founder & Director, PHI’s CAMI Health
Podcast: Understanding Extreme Heat’s Causes and Symptoms
Dr. Linda Rudolph, of PHI’s Center on Climate Change and Health, discusses the impact extreme heat has on our communities and older adults.
Dr. Thyonne Gordon speaks with Dr. Linda Rudolph, a public health physician and Director of the Center for Climate Change and Health at the Public Health Institute, and Enrique Huerta, Legislative Director at Climate Resolve. Together the trio discuss the impact extreme heat has on communities and older adults, as well as what actions can be taken to protect ourselves and our loved ones.
Listen To The Podcast:
See a clip from the podcast, with tips from Dr. Rudolph on staying safe and cool during heat events:
Podcast: Emerging Trends in Addiction Medicine
In this podcast series, PHI’s CA Bridge shares strategies for how hospitals and health care providers can address the overdose crisis with evidence-based care.
PHI’s CA Bridge save lives by making it possible for people who use drugs to get treatment at any hospital—whenever and wherever they need it.
The Emerging Trends series shares learnings from hospitals that are advancing overdose prevention and treatment, featuring insights from hospitals that are part of the CA Bridge Centers of Excellence project. Topics include: best practices for low-threshold access to buprenorphine treatment for opioid use disorder; emerging treatment pathways for stimulant use disorder; post-overdose care; and more.
Episode 6: Case Studies on Precipitated Withdrawal
Real world case studies on precipitated withdrawal are discussed.
Episode 5: Just Start It: Buprenorphine Self-Starts
Starting patients in withdrawal on buprenorphine is safe – so safe in fact, patients can successfully do it on their own. We’ll talk through the details of how to prescribe buprenorphine self-starts and the coaching for patients that goes with it.
Episode 4: Innovations in Post Overdose Care
Starting post-overdose buprenorphine is safe and saves lives at a moment when patients are most at risk for a repeat overdose and death. Combining effective treatment with suicide screening can save even more lives.
Presenters: Leslie Mukau, MD and Aimee Moulin, MD
Episode 3: New Best Practices in Harm Reduction: Fentanyl Test Strips, HCV/HIV Testing, and More
Naloxone saves lives, but a functioning take-home naloxone program should be just one component of wraparound harm reduction services from the emergency room. Learn the latest best practices including fentanyl test strips, STD testing, and more
Presenters: Josh Luftig, PA-C and Arianna Sampson, PA-C
Episode 2: Precipitated Withdrawal: What You Need to Know
Precipitated withdrawal prompted by buprenorphine initiation doesn't have to be scary for the patient or provider. Learn how to avoid it with smart and proven treatment.
Episode 1: Buprenorphine Starts for Fentanyl Use
Facts vs Fear: As fentanyl spreads in many communities, buprenorphine is still an effective tool for treating patients with just a few clinical tweaks.
Presenters: Hannah Snyder, MD & Erik Andersen, MD
More ways to listen and subscribe
- Listen on Spotify
- Listen on Google Podcasts
- Listen on Amazon Music
- Listen on Podcast Addict
Podcast: Designing Health into Everyday Life with PHI’s Building H
On this podcast, PHI’s Steve Down and Thomas Goetz, co-founders of PHI’s Building H, discuss how the program and their collaborators are developing tools to help companies understand the impacts of their products and services on the health and well-being of their users.
Is the everyday world making us sick? Can we hold companies responsibility for the health consequences of their products and services? How do you design health into the operating systems of our civilization?
On the episode “Designing Health into Everyday Life” of the podcast Design Lab with Bon Ku, Steve Down and Thomas Goetz, co-founders of PHI’s Building H program, discuss how Building H and their collaborators are developing tools to help companies understand the impacts of their products and services on the health and well-being of their users.
Listen to the podcastListen to the podcast to learn about these topics:
- How companies are impacting the health of individuals.
- How Building H measures a company’s impact on health.
- How companies can use the index to design new products and services to support our health.
Ultimately, what we are trying to do, just as these products have on their users' behavior, we are trying to have an impact on the companies’ behavior and trying to help them understand that these issues have really been invisible. By putting them out there, hopefully, they’ll recognize that there is an opportunity. If their users come out healthier and feel more positive and sustained by using your product, that is a good metric.Thomas Goetz
PHI’s Building H co-founder
Building H is a not-for-profit project which aims to reverse the course of chronic disease in the U.S. by building health into everyday life. We believe the infrastructure of our daily life—our food, our transportation and housing, and our entertainment—can be reimagined with health and well-being as explicit design goals.
NACCHO Podcast: PHI’s Dr. Mary A. Pittman Discusses Healthy People 2030
In this NACCHO Podcast from Washington episode, PHI’s President and CEO Dr. Mary Pittman joins NACCHO’s Ian Goldstein to speak about the goals of the Healthy People 2030 initiative.
Healthy People identifies public health priorities to help individuals, organizations, and communities across the United States improve health and well-being. Healthy People 2030—the initiative’s fifth iteration—builds on knowledge gained over the first four decades, and includes 355 core, measurable objectives as well as developmental and research objectives. PHI President and CEO Mary A. Pittman serves as a member of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for Healthy People 2030.
On this Podcast from Washington, Dr. Pittman joins NACCHO’s Ian Goldstein to speak about the goals of the Healthy People 2030 initiative, and how PHI is incorporating those objectives into its work. She also shares tips for how state-led organizations and health departments can engage stakeholders in adopting the Healthy People 2030 framework.
Dr. Pittman’s interview begins at roughly 12:50.
Hear the podcast
The community-based organizations that have been our partners throughout COVID have to be continued as our partners post-COVID—because that’s the real base of our ability to create the healthiest population.Dr. Mary Pittman, PHI’s President and CEO, & Member of the Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for Healthy People 2030
Learn more about the PHI programs and projects, discussed by Dr. Pittman:
- The Healthy Places Index (HPI): The California Healthy Places Index (HPI) is a powerful tool, developed by PHI’s Public Health Alliance of Southern California, to assist communities in exploring local factors that predict life expectancy and comparing community conditions across the state. The HPI provides overall scores and more detailed data on specific policy action areas that shape health, like housing, transportation, education and more.
- Health in All Policies: Health in All Policies (HiAP) is a collaborative approach to improving the health of all people by incorporating health considerations into decision-making across sectors and policy areas. PHI’s first-in-the-country HiAP team provides technical support for initiatives in local governments and municipalities, at the state level, and in countries outside the U.S.
- Supporting communities in responding to COVID-19: PHI and its programs are working rapidly to respond to COVID-19, on local, national and global levels. PHI’s programs are working within and alongside our most-impacted communities, organizing contact tracing efforts, creating a workforce from within impacted neighborhoods, working with trusted leaders, messengers and community-based organizations to dismantle barriers to vaccine access, and partnering with private, governmental and philanthropic sectors to bolster efforts. Learn more about how PHI and programs are responding to COVID and working with communities to support vaccine equity.
Webinar Recording: DDT Exposure in Grandmothers Linked to Obesity, Earlier Periods in Granddaughters
New Meaning of “Persistence” for an Environmental Chemical Banned 50 Years Ago
In this webinar, Dr. Cohn, director of PHI’s Child Health and Development Studies, discussed her recent research which found that young women today may face increased health risks linked to breast cancer due to their grandmothers’ exposure to the banned pesticide DDT.
Learn more about the studyThis was the first study to report on the health effects of exposure to a toxic environmental chemical over three human generations, and found that granddaughters whose grandmothers were exposed to the pesticide DDT have higher rates of obesity and earlier first menstrual periods. This may increase the granddaughters’ risk for breast cancer as well as high blood pressure, diabetes and other cardiometabolic diseases.
This research was conducted by PHI’s Child Health and Development Studies where 15,000 pregnant women donated blood samples during and shortly after their pregnancies in the 1960s. These women have been followed for their own health and the health of their daughters and granddaughters for over 60 years.
This work is the first to show such a 3 generation effect for a pesticide in humans and gives new meaning to the idea of “forever” chemicals. Dr. Cohn discussed what this study means for current generations of women and current environmental issues.
This webinar is one in a monthly series sponsored by the Collaborative on Health and the Environment’s EDC Strategies Partnership.
Featured Speaker: Barbara A. Cohn
Barbara A. Cohn, PhD, is director of the Child Health and Development Studies (CHDS) at PHI. CHDS is home to a groundbreaking study, which originated in 1959, designed to shed light on the various factors impacting health during pregnancy and early childhood. Between 1959 and 1967, 15,000 pregnant women and their families were enrolled. Researchers continue to study these rich data and conduct important follow-up studies to further examine how events during pregnancy impact the subsequent health of fathers, mothers and their children and grandchildren. Cohn consults with researchers around the world on the use of the CHDS data for health research.
In addition, Cohn directs research examining how pregnancy protects against breast cancer and influences other health problems in mothers and their children in order to identify natural protective mechanisms that can be used for prevention. She also investigates whether early life exposure to environmental chemicals during pregnancy affects obesity, immune function, reproductive health, cardiovascular disease, diabetes, neurodevelopment, cancer, and health disparities in mothers and their children across the life span.
Cohn holds a doctorate in epidemiology, a master’s degree in city and regional planning, a master’s degree in public health planning and a bachelor’s degree in zoology, all from the University of California, Berkeley.
Going Viral: Marta Induni Joins Paula Poundstone to Discuss Contact Tracing
Listen to PHI’s Marta Induni talk about contact tracing with Paula Poundstone. Find out more about how contact tracing works and why it is so critical in fighting COVID, on Nobody Listens to Paula Poundstone.
With the surge of COVID-19 cases in the U.S., contact tracing has become vital in stopping COVID-19. In this episode of Nobody listens to Paula Poundstone, PHI’s Marta Induni discussed PHI’s Tracing Health—one of the earliest contact tracing initiatives in the U.S.—and how the initiative helps support communities that have been most adversely affected.
Listen here
“Is COVID-19 Outpacing Test and Contact Tracing?” Podcast with Marta Induni of PHI’s Tracing Health Program
On this podcast episode of “A Shot in the Arm,” Dr. Marta Induni of PHI’s Tracing Health program discusses whether COVID-19 testing and contact tracing programs are reaching the people in need, what have we learned, and where we go from here.
In the latest “Shot in the Arm” podcast, PHI’s Dr. Marta Induni gives an update on the Tracing Health program and discusses contact tracing in the communities most impacted by COVID-19. The series on COVID-19 is a collaboration between the podcast and the Bay Area Global Health Alliance.
“We teach our staff through ‘trauma informed training.’ We are working with traumatized communities and our contact tracers are from those communities.”
Dr. Marta Induni, Tracing Health
A Shot in the Arm podcast
You can also watch Mary Pittman, PHI President and CEO and Board Chair of the Bay Area Global Health Alliance discussing “COVID-19: Public Health on the Line” on a previous episode of the Shot in the Arm podcast.
Work With Us
You change the world. We do the rest. Explore fiscal sponsorship at PHI.
Support Us
Together, we can accelerate our response to public health’s most critical issues.
Find Employment
Begin your career at the Public Health Institute.
